Cell-Free Enzyme Assays for Rapid Toxicity Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current toxicity testing methods, particularly for dermal corrosion, are labor-intensive, time-consuming, and rely heavily on live animals, raising ethical concerns and lacking rapid, accurate non-animal alternatives.
Innovation Solution
An in chemico, cell-free method using predefined enzymes or enzyme mixtures to measure reductions in enzymatic activity in response to test substances, predicting tissue toxicity without binding specifically to enzyme active sites, and comparing the measured activity to control values.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If live animal testing is used for toxicity assessment, then traditional toxicity data can be obtained, but ethical concerns arise, animal suffering occurs, and study costs and duration increase
Solution Approach 1:
The patent extracts the essential toxicity assessment function from live animal testing by using cell-free enzymatic systems. The predefined enzymes perform the toxicity detection function without requiring living animals, thereby eliminating animal suffering while maintaining the ability to assess tissue toxicity through enzymatic activity measurements.
Solution Approach 2:
The patent creates a simplified copy of the toxicity testing system using cell-free enzyme preparations instead of live animals. The enzymes are predefined and purified forms that replicate the essential detection function without the complexity and ethical issues of living organisms, enabling toxicity assessment through biochemical reactions rather than whole animal studies.
2Reliability
If traditional live animal toxicity tests are used, then comprehensive toxicity data can be obtained, but the tests are labor-intensive and time-consuming
Solution Approach 1:
The patent extracts the toxicity detection function from complex live animal studies and implements it through simplified cell-free enzymatic assays. The predefined enzymes enable rapid toxicity screening without the lengthy procedures required for animal studies, significantly improving testing throughput while maintaining classification accuracy.
Solution Approach 2:
The patent changes the fundamental parameter of the testing system from living organisms to purified enzymes. This parameter change transforms the testing process from time-consuming animal studies to rapid biochemical measurements, enabling high-throughput toxicity screening through quantifiable enzymatic activity changes.
3Productivity
If in chemico cell-free methods are used, then testing time and cost are reduced, but the methods must be validated to ensure accuracy comparable to animal tests
Solution Approach 1:
The patent employs predefined enzymes that can assess multiple types of tissue toxicity (dermal, ocular, respiratory, hepatic, renal, neurological) using a single cell-free platform. This universal approach enables rapid screening across different toxicity endpoints without requiring separate validation for each tissue type, improving both productivity and reliability.
Solution Approach 2:
The patent incorporates control values and reference standards into the enzymatic assay system to provide feedback for accuracy assessment. By comparing test results against predefined control measurements and validation data, the system ensures that the simplified enzymatic method produces reliable toxicity predictions comparable to traditional animal testing.
4Productivity
If enzymes are used to measure toxicity, then rapid and shelf-stable results can be obtained, but the enzymes must not bind specifically to active sites to avoid false results
Solution Approach 1:
The patent uses predefined enzymes as intermediary molecules that mediate the toxicity detection process. These enzymes interact with test substances in a controlled manner, producing measurable enzymatic activity changes that indicate toxicity without requiring specific binding to active sites. The enzymes serve as reliable intermediaries that translate toxicity into quantifiable biochemical signals.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides a rapid, shelf-stable, and cost-effective means to predict dermal corrosion and irritation by measuring enzymatic activity reduction, offering a reliable alternative to traditional live animal tests.
Implementation Method 1
measuring any reduction in enzymatic activity of the predefined enzyme or enzyme mixture on a predefined substrate
Data Source
AI summary
The disclosure relates to formulations and methods for the in chemico testing of toxins based on a discovery that measuring a reduction in enzyme activity can be used to predict in vivo toxicity, including for example, a skin corrosion, skin irritation, eye corrosion, eye irritation, lung toxicity, liver toxicity, nervous system toxicity, developmental toxicity, acute toxicity etc. Disclosed methods are rapid, easy to perform and shelf-stable approaches for identification of toxic chemicals and materials.